Doctors rely on the drug heparin, a blood thinner, to prevent blood clots during surgery and kidney dialysis. But they also rely on protamine, which binds heparin and blocks its action, to restore ...

The short answer is: No. There is no evidence at all for the use of heparin in the treatment of stroke. The longer answer is a bit more complicated. We have to distinguish among several types of ...

Researchers moved one step closer to the ability to make heparin in cultured cells. Heparin is a potent anti-coagulant and the most prescribed drug in hospitals, yet cell-culture-based production of ...

A synthetic form of low-molecular-weight heparin has been created that can be reversed in cases of overdose and would be safer for patients with poor kidney function. Heparin is an anticoagulant, and ...

Heparin-induced thrombocytopenia is a prothrombotic drug reaction caused by anti–platelet factor 4 (PF4)–heparin antibodies of the IgG class that activate platelets through platelet Fcγ receptors. 1 ...

Thrombocytopenia associated with heparin therapy is a serious complication that is seen in the inpatient clinical setting. There are two types of heparin-induced thrombocytopenia, nonimmunologic (type ...

Medical materials company Instrumentation Laboratory Co. reports that the U.S. Food and Drug Administration has given the Bedford-based company approval to sell its test for determining the ...

Troy, N.Y. – Researchers at Rensselaer Polytechnic Institute and the University of North Carolina at Chapel Hill (UNC) have created a synthetic form of low-molecular-weight heparin that can be ...